This is a public record generated listing.
Assets of Maryland Pharmaceutical Company
Listing Information
Attachments
Assets of Maryland Pharmaceutical Company
Price: $37,000,000.00
Other Item Info
Item #: mdbke_772644
Created: 06/19/2023
Category: Business Property > All Assets or Going Concerns > Pharmaceuticals & Biotechnology
Sale Date: Fri. Jun 23, 2023
Created: 06/19/2023
Category: Business Property > All Assets or Going Concerns > Pharmaceuticals & Biotechnology
Sale Date: Fri. Jun 23, 2023
Seller Info
Stephen Metz
Debtor's Attorney
7501 Wisconsin Ave, Suite 1000W
Bethesda, MD 20814
240-507-1723
Debtor's Attorney
7501 Wisconsin Ave, Suite 1000W
Bethesda, MD 20814
240-507-1723
Bankruptcy Info
Case #: 0:23-bk-12201
Case Title: Wellstat Therapeutics Corporation and Wellstat Biologics Corporation
Court: Maryland Bankruptcy Court
Chapter: 7
View Case Docket
Case Title: Wellstat Therapeutics Corporation and Wellstat Biologics Corporation
Court: Maryland Bankruptcy Court
Chapter: 7
View Case Docket
Description
Sale of all assets of Wellstat Therapeutics Corporation and Wellstat Biologics Corporation includes its intellectual property, inventory and other assets associated with FDA-approved drugs that are currently on the market for patient use and/or drugs and/or other applications in development.
You can contact the Seller (above) or click on the case # in the bankruptcy case information section to find additional documents and descriptions regarding the assets for sale.
Financial Overview
Income and Expenses ($)
months
Revenue/Gross Income:
Total Expenses:
Cash Flow:
Asset and Liability Summary ($)
Receivables:
Inventory:
FF&E:
Real Estate:
Total Assets:
Liabilities to assume:
Additional Details
- Auction Time: 9:00 A.M
- Sale hearing on June 27, 2023 at 2:00 p.m.
- Bid increment: $100,000 over the then existing highest Bid
- Bid deadline: June 20, 2023
- Last date to respond: June 26, 2023